Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial

Neurology

Volumn 46, Issue 5, 1996, Pages 1306-1310

  Simpson, D M ^a,e   Alexander, D N ^b   O'Brien, C F ^c   Tagliati, M ^a   Aswad, A S ^d   Leon, J M ^d   Gibson, J ^d   Mordaunt, J M ^d   Monaghan, E P ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Colorado Neurological Institute ^*  (United States)

^d ALLERGAN INC   (United States)

^e MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; MUSCLE TONE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPASTICITY; STROKE; TREATMENT OUTCOME;

EID: 0029951449     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.46.5.1306     Document Type: Article

References (20)

1. Young RR. Treatment of spastic paresis. N Engl J Med 1989; 320:1553-1555.
2. Young RR. Physiologic and pharmacologic approaches to spasticity. Neurol Clin 1987;5:529-539.
3. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: disordered motor control. Chicago: Year Book Medical Publishers, 1980:485.
4. Little JW, Merritt JL. Spasticity and associated abnormalities of muscle tone. In: Delisa JA, ed. Rehabilitation medicine: principles and practice. Philadelphia: Lippincott, 1988:565-584.
5. Cartlidge NE, Hudgson P, Weightman D. A comparison of baclofen and diazepam in the treatment of Spasticity. J Neurol Sci 1974;23:17-24.
6. Garland DE, Menachem L, Keenan MA. Percutaneous phenol blocks to motor points of spastic forearm muscles in head-injured adults. Arch Phys Med Rehabil 1984;65:243-245.
7. Keenan MAE, Eufrocina ST, Stone L, Gersten LM. Percutaneous phenol block of the musculocutaneous nerve to control elbow flexor Spasticity. J Hand Surg 1990;15A:340-346.
8. Simpson LL, ed. Peripheral actions of the botulinum toxins. In: Botulinum neurotoxin and tetanus toxin. San Diego, CA: Academic Press, 1989:153-178.
9. Jankovic JJ, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.
10. AAN. Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1990;40:1332-1336.
11. Das TK, Park DM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 1989;65:208-210.
12. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik H. Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239:375-378.
13. Hesse S, Friedrich H, Domasch C, Mauritz KH. Botulinum toxin therapy for upper limb flexor spasticity: preliminary results. J Rehab Sci 1992;5:98-101.
14. Mémin B, Pollak P, Hommel M, Perret J. Effects of botulinum toxin on spasticity. Rev Neurol 1992;148:212-214.
15. Pierson SH, Katz DI, Tarsy D. Botulinum toxin A (BTA) in the treatment of spasticity [abstract]. Neurology 1994; 44(Suppl 2):A184.
16. Tsui JKC, O'Brien CF. Clinical trials for spasticity. In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, Inc. 1994:523-534.
17. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990;28:512-515.
18. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995;45:712-717.
19. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964;192:540-542.
20. Albright AL, Barron WB, Fasick MP, Ploinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270:2475-2477.